Vito Imbasciani

The board meeting focused on several key topics, including recent outreach activities such as ribbon-cutting ceremonies at the Lungquist Institute and presentations to veteran organizations. The leadership reported on congressional visits and stakeholder engagements regarding cell and gene therapy access. A significant portion of the meeting was dedicated to reviewing the long-term budget forecast, specifically discussing the shift to an eight-year deployment model to better align funding with clinical readiness, the rebalancing of resources across discovery, preclinical, and clinical pillars, and strategies for ensuring the sustainability of the Alpha Clinics after the current funding cycle.

The Subcommittee held a meeting to discuss communications metrics, team budget priorities for the 2026-2027 fiscal year, and the frequency of future meetings. A significant portion of the discussion focused on the evolving communications landscape, specifically the increasing role of artificial intelligence in content discovery and the necessity for strategies that optimize organizational visibility within these new digital channels. Additionally, the group reviewed current outreach efforts, website performance, and potential growth opportunities within various social media platforms.

The committee discussed the evolving communications landscape, focusing on the shifting reliance from search engines to artificial intelligence for information gathering. Key discussion topics included the committee's mission to drive awareness and support for programs, the impact of AI on web traffic, and the necessity of prioritizing public relations to leverage third-party validation. Further items covered were technical plans to consolidate the blog into the primary website to improve content visibility for AI indexing, the importance of in-person outreach to tell emotionally resonant stories, and the need for future policy development regarding organizational transparency in the utilization of AI.

The joint meeting of the Finance and Science Subcommittees focused on several agenda items. Key discussions included the consideration of the Data and Software Engineering Infrastructure Concept Plan, amendments to the Preclinical Development (PDEV) and Rare Disease Acceleration Platform and Innovation and Delivery (RAPID) concept plans, and a discussion of the patient perspective score proposal. Additionally, the subcommittees reviewed the research and administrative budgets for FY 26-27.

The committee discussed the proposed concept plan for data science and software engineering awards, specifically focusing on the infrastructure needed for data integration in regenerative medicine. Key topics included the importance of open-source software, the challenges of managing diverse and siloed biomedical datasets, and the need for scalable software tools. The subcommittee reviewed the eligibility, award structure, and outreach plans for this potential funding program, and held a vote to endorse moving the concept plan forward to the full board for approval.